- Home
- RGEN vs MKSI Comparison
RGEN vs MKSI Comparison
Compare RGEN & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- MKSI
- Stock Information
- Founded
- RGEN 1981
- MKSI 1961
- Country
- RGEN United States
- MKSI United States
- Employees
- RGEN N/A
- MKSI N/A
- Industry
- RGEN Medical/Dental Instruments
- MKSI Industrial Machinery/Components
- Sector
- RGEN Health Care
- MKSI Industrials
- Exchange
- RGEN Nasdaq
- MKSI Nasdaq
- Market Cap
- RGEN 7.6B
- MKSI N/A
- IPO Year
- RGEN N/A
- MKSI 1999
- Fundamental
- Price
- RGEN $156.55
- MKSI $111.11
- Analyst Decision
- RGEN Buy
- MKSI Strong Buy
- Analyst Count
- RGEN 12
- MKSI 11
- Target Price
- RGEN $187.44
- MKSI $143.00
- AVG Volume (30 Days)
- RGEN 470.1K
- MKSI 701.3K
- Earning Date
- RGEN 02-19-2025
- MKSI 02-05-2025
- Dividend Yield
- RGEN N/A
- MKSI 0.79%
- EPS Growth
- RGEN N/A
- MKSI N/A
- EPS
- RGEN N/A
- MKSI 0.45
- Revenue
- RGEN $633,513,000.00
- MKSI $3,544,000,000.00
- Revenue This Year
- RGEN $2.28
- MKSI $0.41
- Revenue Next Year
- RGEN $9.88
- MKSI $8.06
- P/E Ratio
- RGEN N/A
- MKSI $245.43
- Revenue Growth
- RGEN N/A
- MKSI N/A
- 52 Week Low
- RGEN $113.50
- MKSI $97.54
- 52 Week High
- RGEN $211.13
- MKSI $147.40
- Technical
- Relative Strength Index (RSI)
- RGEN 60.07
- MKSI 53.46
- Support Level
- RGEN $149.15
- MKSI $105.34
- Resistance Level
- RGEN $160.64
- MKSI $116.63
- Average True Range (ATR)
- RGEN 5.96
- MKSI 3.14
- MACD
- RGEN 0.91
- MKSI 0.50
- Stochastic Oscillator
- RGEN 79.57
- MKSI 61.53
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.